We are studying normal and abnormal human brain development from the aspect of neural stem cell metabolism. Our group also focuses on the metabolic vulnerabilities of human glioblastoma. Our long-term aim is to establish new diagnostic tools and therapeutic strategies for neurodevelopmental disorders and glioblastoma.